Your browser doesn't support javascript.
loading
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection.
Marking, Ulrika; Bladh, Oscar; Havervall, Sebastian; Svensson, Julia; Greilert-Norin, Nina; Aguilera, Katherina; Kihlgren, Martha; Salomonsson, Ann-Cristin; Månsson, Maja; Gallini, Radiosa; Kriegholm, Cecilia; Bacchus, Philip; Hober, Sophia; Gordon, Max; Blom, Kim; Smed-Sörensen, Anna; Åberg, Mikael; Klingström, Jonas; Thålin, Charlotte.
Afiliação
  • Marking U; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Bladh O; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Havervall S; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Svensson J; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Greilert-Norin N; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Aguilera K; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Kihlgren M; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Salomonsson AC; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Månsson M; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Gallini R; Department of Medical Sciences, Clinical Chemistry and SciLifeLab, Uppsala University, Uppsala, Sweden.
  • Kriegholm C; Department of Medical Sciences, Clinical Chemistry and SciLifeLab, Uppsala University, Uppsala, Sweden.
  • Bacchus P; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Hober S; Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
  • Gordon M; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden.
  • Blom K; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden; Public Health Agency of Sweden, Solna, Sweden.
  • Smed-Sörensen A; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Åberg M; Department of Medical Sciences, Clinical Chemistry and SciLifeLab, Uppsala University, Uppsala, Sweden.
  • Klingström J; Public Health Agency of Sweden, Solna, Sweden; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Thålin C; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, 18288, Sweden. Electronic address: charlotte.thalin@ki.se.
Lancet Infect Dis ; 23(2): 150-152, 2023 02.
Article em En | MEDLINE | ID: mdl-36640796
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina A / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina A / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia